New White Paper: The Microbiome and Immuno-Oncology
Mentoring the Next Generation of Life Science Innovators
Back Bay Report on Neoantigen-Based Cancer Immunotherapy
Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper
Asia Opens Its Doors for Pre-Revenue Biotechs
2018 Transactional Trends: Key Issues for Cross-Border Deals; Focus on Emerging and Mid-Size Companies
Back Bay Celebrates 8 Years and 450 Life Science Assignments
What Should Be Done About the Shrinking Number of US Public Companies?
Precision Medicine and the Age of Collaboration
Back Bay Biopharma Confidence Index
Acquiror or Acquiree? The Role of M&A "Deal Heat" in Premium Valuations
Drug Pricing: Asking the Right Questions
Back Bay Rowers Take Four First Place Medals at The Head of the Charles Regatta
100 Years Later, Legacy of Patient Care Carries Us Forward
Life Science Mentoring: Back Bay Sponsors Tufts New England Case Competition
Mass Bio: Industry & Academia, Begin with the End in Mind
The Future of Payment Reform: Looking to the CMMI for Hints
Blog: Volatility Impacts Frequency of Option-Related Deals
Blog: Issues Facing Specialty Pharmacies
JP Morgan Healthcare Conference 2015 Recap, 2016 Outlook
